ID   UTE4
AC   CVCL_VK04
DR   Cosmic; 2640555
DR   Wikidata; Q98134401
RX   PubMed=27894751;
CC   Microsatellite instability: Stable (MSS) (PubMed=27894751).
CC   Sequence variation: Mutation; HGNC; HGNC:9177; POLE; Simple; p.Ala957Val; Zygosity=Unspecified (PubMed=27894751).
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 6
//
RX   PubMed=27894751; DOI=10.1016/j.ygyno.2016.11.023; PMCID=PMC5183545;
RA   Bellone S., Bignotti E., Lonardi S., Ferrari F., Centritto F.,
RA   Masserdotti A., Pettinella F., Black J.D., Menderes G., Altwerger G.,
RA   Hui P., Lopez S., de Haydu C., Bonazzoli E., Predolini F.,
RA   Zammataro L., Cocco E., Ferrari F., Ravaggi A., Romani C.,
RA   Facchetti F., Sartori E., Odicino F.E., Silasi D.-A., Litkouhi B.,
RA   Ratner E., Azodi M., Schwartz P.E., Santin A.D.;
RT   "Polymerase epsilon (POLE) ultra-mutation in uterine tumors correlates
RT   with T lymphocyte infiltration and increased resistance to
RT   platinum-based chemotherapy in vitro.";
RL   Gynecol. Oncol. 144:146-152(2017).
//